BRKRP
Bruker Corporation
Set alert
- YTD
- +15.41%
- 1 year
- +36.90%
- Open
- 435.30
- Prev close
- 454.20
- Mkt cap
- 9.45B
- Vol
- 14.02K
- Avg vol
- 5.69K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 3.51%
More statistics
- Low
- 413.80
- High
- 435.30
- Forward P/E
- 0.00
- Beta
- 1.22
- Short ratio
- 0.05
- Inst. own
- 99.40%
- Dividend
- 15.94
- Ex-div date
- Aug 13, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 434.84
- 200-d avg
- 379.82
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 70.93B
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 26.82
- EPS (TTM)
- 0.00
- Beta
- 1.22
- Dividend yield
- 3.51%
- Payout ratio
- 0.00%
- Profit margin
- -2.04%
- Revenue (TTM)
- 3.50B
- Revenue growth
- 5.20%
- Free cash flow
- 179.94M
- Total cash
- 184.90M
- Total debt
- 1.86B
- Return on equity
- -3.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 434.84
- 200-day average
- 379.82
Analyst view
Consensus: none
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 0.4188 | — | — | — |
| Aug 4, 2026 | Jun 30, 2026 | 0.3848 | 0.49 | +0.11 | +27.34% |
| May 6, 2026 | Mar 31, 2026 | 0.2294 | 0.31 | +0.08 | +35.14% |
| Feb 12, 2026 | Dec 31, 2025 | 0.65 | 0.59 | -0.06 | -9.23% |
| Nov 3, 2025 | Sep 30, 2025 | 0.3537 | 0.45 | +0.10 | +27.23% |
| Aug 4, 2025 | Jun 30, 2025 | 0.4115 | 0.32 | -0.09 | -22.24% |
About Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- bruker.com
News
Your note
Sign in to keep a note on BRKRP — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Aequim Alternative Investments LP | 21.01% | 580,000 | 243.19M | Jun 29, 2026 |
| FMR, LLC | 16.18% | 446,550 | 187.23M | Jun 29, 2026 |
| Shaw D.E. & Co., Inc. | 7.43% | 205,000 | 85.95M | Jun 29, 2026 |
| Franklin Resources, Inc. | 7.25% | 200,000 | 83.86M | Jun 29, 2026 |
| TPG GP A, LLC | 6.36% | 175,500 | 73.59M | Jun 29, 2026 |
| Blackrock Inc. | 6.22% | 171,695 | 71.99M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Preferred and Income Securities ETF | 6.06% | 167,320 | 70.16M | Sep 29, 2026 |
| Franklin Investors Securities TRT-FRANKLIN CONVERTIBLE SECURITIES Fd. | 5.67% | 156,400 | 65.58M | Jul 30, 2026 |
| Fidelity Securities Fund-Fidelity Growth & Income Portfolio | 5.57% | 153,628 | 64.41M | Aug 30, 2026 |
| CALAMOS INVESTMENT TRUST/IL-Calamos Market Neutral Income Fund | 3.62% | 100,000 | 41.93M | Jul 30, 2026 |
| Fidelity Hastings Street Trust-Fidelity Series Large Cap Stock Fund | 3.16% | 87,200 | 36.56M | Aug 30, 2026 |
| VanEck ETF Trust-VanEck Preferred Securities ex Financials ETF | 2.54% | 70,055 | 29.37M | Sep 29, 2026 |